NYSE:DHRLife Sciences
Danaher (DHR): Assessing Valuation in Light of Legal Scrutiny and Evolving Financial Performance
If you’re holding shares in Danaher (DHR) or thinking about getting in, the past week’s headlines probably caught your eye. News of an ongoing legal investigation into possible fiduciary breaches by Danaher’s executive team arrived just as analysts were digesting another set of uneven financials. With investors suddenly recalibrating risk, these events have put the spotlight back on corporate governance and the company’s path forward.
It has been a challenging year for Danaher, with shares...